Aberdeen Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $5.67M | Sell |
43,975
-3,444
| -7% | -$444K | 0.02% | 444 |
|
|
2017
Q1 | $5.19M | Buy |
47,419
+4,030
| +9% | +$441K | 0.02% | 450 |
|
|
2016
Q4 | $3.2M | Sell |
43,389
-3,173
| -7% | -$234K | 0.01% | 504 |
|
|
2016
Q3 | $4.06M | Sell |
46,562
-160
| -0.3% | -$14K | 0.01% | 466 |
|
|
2016
Q2 | $4.02M | Sell |
46,722
-465
| -1% | -$40K | 0.01% | 451 |
|
|
2016
Q1 | $3.75M | Sell |
47,187
-4,881
| -9% | -$388K | 0.01% | 468 |
|
|
2015
Q4 | $5.7M | Buy |
52,068
+8,513
| +20% | +$932K | 0.02% | 397 |
|
|
2015
Q3 | $4.54M | Sell |
43,555
-2,286
| -5% | -$238K | 0.02% | 390 |
|
|
2015
Q2 | $5.66M | Sell |
45,841
-890
| -2% | -$110K | 0.02% | 369 |
|
|
2015
Q1 | $5.51M | Sell |
46,731
-5,601
| -11% | -$661K | 0.01% | 367 |
|
|
2014
Q4 | $6.22M | Sell |
52,332
-13,809
| -21% | -$1.64M | 0.02% | 342 |
|
|
2014
Q3 | $7.43M | Sell |
66,141
-7,946
| -11% | -$893K | 0.02% | 356 |
|
|
2014
Q2 | $7.02M | Buy |
74,087
+49,587
| +202% | +$4.7M | 0.01% | 390 |
|
|
2014
Q1 | $1.73M | Buy |
24,500
+1,300
| +6% | +$91.9K | ﹤0.01% | 363 |
|
|
2013
Q4 | $1.71M | Hold |
23,200
| – | – | ﹤0.01% | 336 |
|
|
2013
Q3 | $1.76M | Buy |
+23,200
| New | +$1.76M | 0.01% | 320 |
|